Business
Mayne chases larger slice of US contraception market with China deal – Sydney Morning Herald
Mayne Pharma has found a new Chinese supplier to roll out new pill brands in the US.
“Each product market has about six to eight generic competitors, but we are hoping to grab that additional margin
Continue Reading
-
Noosa News23 hours agoCalls for greater education as growers in WA’s south-west brace for polyphagous shot-hole borer
-
Business23 hours agoWhat it means for shareholders
-
General22 hours agoKim Kardashian not deterred by bar failure
-
Business16 hours agoMacquarie tips more than 20% upside for this ASX mining stock